Single-use bioreactors in 2026: overview
Single-use bioreactors are vessels or systems designed to be discarded after use rather than cleaned and reused. They can reduce cleaning and changeover demands, help limit cross-contamination risks, and support flexible manufacturing—especially for biologics and smaller or changing production runs. The trade-off is reliance on disposable bags and components, which makes materials compatibility, process control and plastic waste central engineering and operational concerns. Scaling performance between vessels also requires reliable characterization of mixing, oxygen transfer and cell response.
Recent work is pushing beyond vessel design toward perfusion, process measurement and reproducibility. In July 2026, East China University of Science and Technology and Alit Biotech Shanghai described a CFD-aided, 500 mL single-use perfusion reactor for high-density cell culture. Also in July 2026, Trier University of Applied Sciences and collaborators reported methods to improve reproducibility in mixing-time measurements. Sartorius AG’s October 2026 patent describes a controlled rocking device, while a University of Siena-led life-cycle assessment from July 2026 compares single-use and stainless-steel units, highlighting waste as a design consideration.
- 1Control drives scale-up: Standardized mixing-time measurements and CFD-aided perfusion designs target persistent challenges in transferring cell-culture performance between single-use systems.
- 2Applications are shifting: In the last 12 months, vaccine-related activity grew 33.1% while overall activity fell 30.4%, pointing to uneven momentum across applications.
- 3Waste enters design: A July 2026 life-cycle assessment comparing single-use and stainless-steel units puts material and waste impacts alongside process flexibility in technology decisions.
Top organizations working on single-use bioreactors
Ranked by Linknovate activity score · last 24 monthsThe activity score adds up the relevance of every patent, publication, grant and news item linking an organization to single-use bioreactors. Showing 7 of 418 organizations.
| # | Organization | Approach | Signals (24 mo) | Momentum | Why it matters |
|---|---|---|---|---|---|
| 1 | 
Thermo Fisher Scientific
Corporate · United States |
Stirred-tank systems | PUB 5 · NEWS 730 | -46% | Supplies single-use bioreactor systems for biopharmaceutical process development and manufacturing, including stirred-tank platforms. |
| 2 | 
Merck Group
Corporate · Germany |
Stirred-tank systems | PAT 2 · PUB 1 NEWS 483 |
-53% | Its Mobius portfolio includes single-use stirred-tank bioreactors and related equipment for biopharmaceutical production. |
| 3 | 
Sartorius AG
Corporate · Germany |
Stirred-tank systems | PAT 13 · PUB 10 NEWS 306 |
-37% | Provides single-use bioreactor systems and process equipment for biopharmaceutical development and manufacturing, including stirred-tank systems. |
| 4 | 
Danaher Life Science
Corporate · United States |
Stirred-tank systems | NEWS 216 | -47% | Through its life-sciences businesses, supplies single-use bioprocessing equipment, including stirred-tank bioreactor platforms. |
| 5 | 
Eppendorf Ag
Corporate · Germany |
Stirred-tank systems | PUB 2 · NEWS 129 | -25% | Its BioBLU line includes single-use stirred-tank bioreactors for cell culture and process development. |
| 6 | 
Lonza Group
Corporate · Switzerland |
General | PUB 4 · NEWS 263 | -43% | Provides biopharmaceutical contract manufacturing and uses single-use bioprocessing technologies in production operations. |
| 7 | 
Cytiva
Corporate · United States |
Stirred-tank systems | PAT 1 · NEWS 118 | -28% | Supplies single-use bioprocessing equipment, including stirred-tank bioreactors and associated bags and systems. |
| 8 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 9 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 10 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
Startups to watch and leading research centers
Startups to watch 3 total
Univercells TechnologiesBelgiumDevelops intensified, modular bioprocess technologies and has patented equipment and methods for carrying out bioprocess steps.
Leading research institutions 357 total
ZHAW Zurich University of Applied SciencesSwitzerlandResearches scalable cell-therapy manufacturing, including perfusion and cell-retention methods for adherent-cell and stem-cell cultures.
East China University of Science and TechnologyChinaRecently, researchers developed and characterized a 500 mL single-use perfusion bioreactor for high-density animal-cell culture.
Trier University of Applied SciencesGermanyStudies mixing-time measurement and reproducibility in stirred single-use bioreactors, including standardized methods for characterizing mixing.- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
Where single-use bioreactors innovation happens
Share of documents with at least one organization from each country.
Open the interactive map with all 418 organizationsMain technical approaches
Last 24 months| Approach | What it is | Documents | Leading organizations |
|---|---|---|---|
| Stirred-tank systems | Impellers provide familiar, adjustable mixing, but shear, bag geometry and scale-dependent flow need careful control. | 350 |
Thermo Fisher Scientific, Sartorius AG, Merck Group |
| Rocking-motion systems | A rocking platform mixes gently and suits flexible bag-based culture, but oxygen transfer and scale-up can constrain operation. | 58 |
Thermo Fisher Scientific, Merck Group, Sartorius AG |
| Orbital-shaken systems | Orbital motion offers straightforward mixing for smaller vessels, but oxygen transfer and uniformity can become harder to maintain as scale changes. | 112 |
Thermo Fisher Scientific, Researchmoz, Dickinson |
| Fixed-bed systems | A fixed bed supports adherent cells on a stationary matrix, but perfusion distribution and access to the culture surface can be challenging. | 106 |
Thermo Fisher Scientific, Sartorius AG, Merck Group |
| Pneumatically mixed systems | Gas-driven mixing avoids mechanical impellers, but aeration and flow conditions must be balanced against cell sensitivity and process needs. | 41 |
Thermo Fisher Scientific, Merck Group, Sartorius AG |
Emerging trends
Last 12 months vs previous 36 monthsTerms whose frequency in the last 12 months grew the most compared with the previous 36 months.
Funding and investment
Recent funding rounds
Recorded grant activity totals $53.3 million across 41 grants since 2020. Listed funding rounds include broad institutional and corporate financing, so their combined value should not be read as dedicated investment in single-use bioreactors.
Patent landscape
Top patent holders · last 24 monthsRecent developments
Latest news, duplicates removed- Sep 2026Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Reagents Market Insights, Analysis and Forecast 2026-2031" has been added to ResearchAndMarkets.com's offering. The global cell culture reagents market is…GlobeNewswire: Research Analysis And Reports
- Sep 2026Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. Global Bioreactors Market…GlobeNewswire - Research Analysis And Reports
- Sep 2026Dublin, Sept. 17, 2026 (GLOBE NEWSWIRE) -- "Global Microcarriers Market Report by Product Type, Consumables, Application, End User, Countries and Company Analysis 2026-2034" has been added to ResearchAndMarkets.com's…GlobeNewswire - Research Analysis And Reports
- Aug 2026Single-Use Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Single-Use Bioprocessing Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035" has been added to ResearchAndMarkets.com's offering. The global…GlobeNewswire: Research Analysis And Reports
- Month 20XXHidden developmentAvailable to registered users with alerts enabled.
Frequently asked questions about single-use bioreactors
What companies are working on single-use bioreactors?
Thermo Fisher Scientific, Merck Group and Sartorius AG are prominent suppliers of single-use bioreactor systems. Danaher Life Science, Eppendorf Ag, Lonza Group, Cytiva and PBS Biotech Inc. are also active. Their offerings include stirred-tank platforms and related bioprocess equipment for development and manufacturing.
Which single-use bioreactors startups are the most promising in 2026?
Univercells Technologies is the startup identified in the available company data. It develops intensified, modular bioprocess technologies and has patented equipment and methods for carrying out bioprocess steps. The data does not provide enough detail to compare the prospects of other startups or rank them.
Which universities and research centers lead single-use bioreactors research?
Recent work includes East China University of Science and Technology’s research on high-density perfusion culture and Trier University of Applied Sciences’ work on reproducible mixing-time measurements. ZHAW Zurich University of Applied Sciences also researches scalable cell-therapy manufacturing, including perfusion and cell-retention methods for adherent-cell and stem-cell cultures.
How much funding has single-use bioreactors received?
Recorded grant activity totals $53,261,527 across 41 grants since 2020. This figure reflects grants associated with the topic in the available data. The funding-round entries include general institutional and corporate financing, so they should not be interpreted as a clean measure of investment dedicated to single-use bioreactor technology.
Who holds the most single-use bioreactors patents?
Sartorius AG is the leading patent holder in the available data, with 13 patents. Koninklijke Phillips N.V. has 3, while the French National Center for Scientific Research, Genentech, Honeywell, Merck Group, Tata Consultancy Services Ltd. and Suez each have 2.
Is single-use bioreactors patent activity growing?
No. Patent activity declined 32.3% in the last-12-month comparison with the previous 12 months. The available 24-month window contains 104 patents. That points to a recent slowdown in patenting, not an absence of development: recent work includes Sartorius AG’s October 2026 patent for a bioreactor rocking device.
What are the latest developments in single-use bioreactors?
In July 2026, East China University of Science and Technology and Alit Biotech Shanghai described a CFD-aided, 500 mL single-use perfusion reactor for high-density cell culture. Trier University of Applied Sciences and collaborators also reported reproducibility methods for mixing-time measurements that month. Sartorius AG’s October 2026 patent concerns a controlled rocking device.
What are the main approaches in single-use bioreactors and how do they differ?
The main approaches include stirred-tank, rocking-motion, orbital-shaken, fixed-bed and pneumatically mixed systems. Stirred tanks use impellers; rocking and orbital systems move the vessel or bag; fixed beds support cells on a matrix; and pneumatic systems use gas to drive mixing. Each approach trades mixing and oxygen transfer performance against shear, scale-up and process requirements.
What are the applications of single-use bioreactors?
Applications in the available data include cell and gene therapies, recombinant proteins, monoclonal antibodies, vaccines and microbial fermentation. Cell and gene therapies have the largest recorded application activity, with 1,043 documents. Vaccine-related activity grew 33.1% in the last-12-month comparison with the previous 12 months.
Which countries lead single-use bioreactors?
The United States leads with 8,565 documents, followed by Germany with 4,215. The United Kingdom, Japan, India, China and Switzerland are also among the countries with substantial recorded activity. Country document counts can overlap through international collaboration, so they are indicators of activity rather than exclusive national shares.